Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction

被引:29
|
作者
Mandviwala, Taher M. [1 ,2 ]
Basra, Sukhdeep S. [2 ]
Khalid, Umair [1 ,3 ]
Pickett, June K. [1 ]
Przybylowicz, Ryle [1 ,4 ]
Shah, Tina [1 ,3 ]
Nambi, Vijay [1 ,3 ]
Virani, Salim S. [1 ,3 ]
Deswal, Anita [1 ,3 ,5 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Div Cardiovasc Med, Houston, TX 77030 USA
[3] Michael E DeBakey VA Med Ctr, Sect Cardiol, Houston, TX 77030 USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA
关键词
BODY-MASS INDEX; WAIST CIRCUMFERENCE; BARIATRIC SURGERY; MORBIDITY; IMPACT; RISK; COMORBIDITIES; METAANALYSIS; CANDESARTAN; POPULATION;
D O I
10.1038/s41366-020-0563-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Limited data exist on the association of obesity with both hospitalization and mortality in patients with heart failure with preserved ejection fraction (HFpEF), especially in the real-world ambulatory setting. We hypothesized that increasing body-mass index (BMI) in ambulatory heart failure with preserved ejection fraction would have a protective effect on these patients leading to decreased mortality and hospitalizations. Methods We studied the relationship between BMI and the time to all-cause mortality, time to heart failure (HF) hospitalization, and time to all-cause hospitalization over a 2-year follow-up in a national cohort of 2501 ambulatory HFpEF patients at 153 Veterans Affairs medical centers. Results Compared with normal BMI, overweight (HR 0.72; 95% CI 0.57-0.91), obesity class I (HR 0.59; 95% CI 0.45-0.77), obesity class II (HR 0.56; 95% CI 0.40-0.77), and obesity class III (HR 0.53; 95% CI 0.36-0.77) were associated with improved survival after adjustment for demographics and comorbidities. In contrast, the time to HF hospitalization showed an inverse relationship, with shorter time to HF hospitalization with increasing BMI compared with normal BMI; overweight (adjusted HR 1.30; 95% CI 0.88-1.90), obesity class I (HR 1.57; 95% CI 1.05-2.34), obesity class II (HR 1.79; 95% CI 1.15-2.78), and obesity class III (HR 1.96; 95% CI 1.23-3.12). However, time to first all-cause hospitalization was not significantly different by BMI groups. Conclusions In a large, national ambulatory HFpEF cohort, despite the presence of the obesity paradox with respect to survival, increasing BMI was independently associated with an increased risk of HF hospitalization and similar risk of all-cause hospitalization. Future longer-term prospective trials evaluating the safety and efficacy of weight loss on morbidity and mortality, in patients with severe obesity and HFpEF are needed.
引用
收藏
页码:1561 / 1567
页数:7
相关论文
共 50 条
  • [1] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher M. Mandviwala
    Sukhdeep S. Basra
    Umair Khalid
    June K. Pickett
    Ryle Przybylowicz
    Tina Shah
    Vijay Nambi
    Salim S. Virani
    Anita Deswal
    International Journal of Obesity, 2020, 44 : 1561 - 1567
  • [2] The "Obesity Paradox" in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction
    Basra, Sukhdeep S.
    Khalid, Umair
    Virani, Salim S.
    Nambi, Vijay
    Aguilar, David
    Jneid, Hani
    Bozkurt, Biykem
    Deswal, Anita
    CIRCULATION, 2013, 128 (22)
  • [3] Obesity and heart failure with preserved ejection fraction: a paradox or something else?
    Marijana Tadic
    Cesare Cuspidi
    Heart Failure Reviews, 2019, 24 : 379 - 385
  • [4] Obesity and heart failure with preserved ejection fraction: a paradox or something else?
    Tadic, Marijana
    Cuspidi, Cesare
    HEART FAILURE REVIEWS, 2019, 24 (03) : 379 - 385
  • [5] Obesity and heart failure with preserved ejection fraction
    Leowattana, Wattana
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (15) : 1591 - 1593
  • [6] Obesity and Heart Failure with Preserved Ejection Fraction
    Koutroumpakis, Efstratios
    Kaur, Ramanjit
    Taegtmeyer, Heinrich
    Deswal, Anita
    HEART FAILURE CLINICS, 2021, 17 (03) : 345 - 356
  • [7] Difference in pattern of mortality between heart failure with reduced ejection fraction and heart failure with preserved ejection fraction after hospitalization for acute decompensated heart failure
    Nakashima, M. Mitsutaka
    Sakuragi, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 424 - 424
  • [8] Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
    Angraal, Suveen
    Mortazavi, Bobak J.
    Gupta, Aakriti
    Khera, Rohan
    Ahmad, Tariq
    Desai, Nihar R.
    Jacoby, Daniel L.
    Masoudi, Frederick A.
    Spertus, John A.
    Krumholz, Harlan M.
    JACC-HEART FAILURE, 2020, 8 (01) : 12 - 21
  • [9] Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    Packer, Milton
    Zile, Michael R.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ge, Junbo
    Weerakkody, Govinda J.
    Ou, Yang
    Bunck, Mathijs C.
    Hurt, Karla C.
    Murakami, Masahiro
    Borlaug, Barry A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [10] Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Kirkman, Danielle L.
    Bohmke, Natalie
    Billingsley, Hayley E.
    Carbone, Salvatore
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11